Some new analytical methods can also be selected to further analyze FXR1 molecules by statistical analysis of the relationship between FXR1 and other molecules, such as GCNCRF, DMFGAM, scRNA-seq, GCNAT, DCAMCP, NDALMA.[61–67] Additionally, to validate these hypotheses, further in vitro and in vivo experiments are needed to validate the hypothesis that FXR1 may be a diagnostic/prognostic biomarker for certain cancers and a target for immunotherapy. This evidence concerns the gene FXR1 and cancer.